SCHEMBL19655175

SCHEMBL19655175

c1ccc(-c2nc3ccccc3nc2-n2c3ccccc3c3ccc4c5ccccc5n(-c5cccc6c5oc5ccccc56)c4c32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.38
CASP1 P29466 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 2/20 0.36
CSF1R P07333 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HRH4 Q9H3N8 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
PTGER1 P34995 1/20 0.33
POLB P06746 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281830 0.92 HSD17B10 (0.40) HSD17B10CASP1MEN1KMT2AMAPT
SCHEMBL19655289 0.89 HSD17B10 (0.36) HSD17B10CASP1MEN1KMT2AMAPT
SCHEMBL19655235 0.88 MAPT (0.35) HSD17B10MEN1KMT2AMAPTCSF1R
SCHEMBL19655178 0.88 HSD17B10 (0.37) HSD17B10CASP1MEN1KMT2AHRH4
SCHEMBL19653905 0.87 HSD17B10 (0.36) HSD17B10CASP1MEN1KMT2AMAPT
SCHEMBL19655199 0.86 MEN1 (0.35) HSD17B10MEN1KMT2AMAPTCSF1R
SCHEMBL19655119 0.85 HSD17B10 (0.46) HSD17B10CASP1MEN1KMT2AMAPT
SCHEMBL19655181 0.84 GSR (0.45) HSD17B10CASP1MEN1KMT2AHRH4
SCHEMBL19655184 0.84 HSD17B10 (0.37) HSD17B10CASP1MEN1KMT2AMAPT
SCHEMBL18868298 0.84 KDM4E (0.35) HSD17B10CASP1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840458-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDXK, MT-ND4L, PNPO HSD17B10 3487/4885CASP1 3467/4885MEN1 2827/4885
US-10840458-B2 Organic electroluminescent materials and devices PDXK, MT-ND4L, PNPO HSD17B10 3487/4885CASP1 3467/4885MEN1 2827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.